File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Absolute benefits of empagliflozin in type 2 diabetes: a game changer?

TitleAbsolute benefits of empagliflozin in type 2 diabetes: a game changer?
Authors
Issue Date2017
PublisherBMJ Publishing Group. The Journal's web site is located at http://www.postgradmedj.com
Citation
Postgraduate Medical Journal, 2017, v. 93 n. 1101, p. 373-375 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/246566
ISSN
2021 Impact Factor: 4.973
2020 SCImago Journal Rankings: 0.568
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorKumana, CR-
dc.contributor.authorTan, KCB-
dc.contributor.authorCheung, BMY-
dc.date.accessioned2017-09-18T02:30:44Z-
dc.date.available2017-09-18T02:30:44Z-
dc.date.issued2017-
dc.identifier.citationPostgraduate Medical Journal, 2017, v. 93 n. 1101, p. 373-375-
dc.identifier.issn0032-5473-
dc.identifier.urihttp://hdl.handle.net/10722/246566-
dc.languageeng-
dc.publisherBMJ Publishing Group. The Journal's web site is located at http://www.postgradmedj.com-
dc.relation.ispartofPostgraduate Medical Journal-
dc.rightsPostgraduate Medical Journal. Copyright © BMJ Publishing Group.-
dc.titleAbsolute benefits of empagliflozin in type 2 diabetes: a game changer?-
dc.typeArticle-
dc.identifier.emailKumana, CR: hrmekcr@hku.hk-
dc.identifier.emailTan, KCB: kcbtan@hkucc.hku.hk-
dc.identifier.emailCheung, BMY: mycheung@hkucc.hku.hk-
dc.identifier.authorityTan, KCB=rp00402-
dc.identifier.authorityCheung, BMY=rp01321-
dc.identifier.doi10.1136/postgradmedj-2016-134741-
dc.identifier.scopuseid_2-s2.0-85021730568-
dc.identifier.hkuros277453-
dc.identifier.hkuros281787-
dc.identifier.volume93-
dc.identifier.issue1101-
dc.identifier.spage373-
dc.identifier.epage375-
dc.identifier.isiWOS:000404538900001-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl0032-5473-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats